Doxomax Xp Tablet

Doxomax Xp Tablet is a powerful combination medication designed to manage chronic respiratory conditions such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other airway-related disorders. This dual-action tablet contains Ambroxol, a mucolytic agent, and Doxofylline, a bronchodilator, which work together to improve breathing by clearing mucus and relaxing airway muscles.

• Ambroxol (30 MG) helps thin and loosen mucus trapped in the lungs, making it easier to cough up and expel. This improves airflow and reduces chest congestion.

• Doxofylline (400 MG) belongs to the methylxanthine class of bronchodilators. It relaxes the muscles around the bronchial tubes, allowing the airways to open wider and making breathing easier.

This combination is highly effective for people suffering from productive cough, wheezing, shortness of breath, and tightness in the chest due to excessive mucus and narrowed airways. Unlike older bronchodilators like theophylline, Doxofylline offers a better safety profile with fewer side effects, especially regarding the cardiovascular and central nervous systems.

Physicians often prescribe this tablet as a part of maintenance therapy for patients who experience recurring symptoms or flare-ups due to environmental triggers, allergens, smoking, or infections. It is well-tolerated in adults and provides dual-action relief—mucus clearance and bronchodilation—in one tablet, reducing the need for multiple medications.